Eli Lilly CEO expects new weight loss pill to be approved next year
Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which ...
Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand
Eli Lilly shares dropped after the drugmaker cut its 2024 revenue guidance, citing lower-than-expected demand for its obesity ...
Yahoo Finance3d
Eli Lilly's weight loss pill could get federal approval by early next year
Eli Lilly & Co. (LLY) thinks its next experimental weight-loss pill could get approved as soon as early 2026. CEO Dave Ricks told Bloomberg News on Monday that data on the drug, orforglipron ...
NBC New York3d
Eli Lilly CEO expects new weight loss pill to be approved next year
Eli Lilly expects its experimental weight loss pill, orforglipron, to be approved as soon as early next year, CEO David Ricks told Bloomberg. Eli Lilly and Novo Nordisk, which dominate the market ...
NBC DFW3d
Eli Lilly CEO expects new weight loss pill to be approved next year
Eli Lilly expects ... trial data on the drug, orforglipron, by the middle of this year. Get top local stories in DFW delivered to you every morning. Sign up for NBC DFW's News Headlines newsletter.
NBC Connecticut3d
Eli Lilly CEO expects new weight loss pill to be approved next year
Eli Lilly expects ... on the drug, orforglipron, by the middle of this year. Get top local stories in Connecticut delivered to you every morning. Sign up for NBC Connecticut's News Headlines ...
Business Insider3d
Eli Lilly CEO tells Bloomberg TV company sees weight loss pill approval in 2026
Eli Lilly (LLY) expects that its experimental weight loss pill will get approved as soon ... market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More ...